Integer Holdings (ITGR) Asset Writedowns and Impairment (2021 - 2024)

Integer Holdings (ITGR) reported Asset Writedowns and Impairment of $1.1 million for Q1 2024, up 78.98% sequentially from $590000.0 in Q4 2023.

Integer Holdings (ITGR) Asset Writedowns and Impairment (2021 - 2024) Analysis & Trends

Integer Holdings (ITGR) has 4 years of Asset Writedowns and Impairment data on file, last reported at $1.1 million in Q1 2024.

  • For the quarter ending Q1 2024, Asset Writedowns and Impairment changed N/A year-over-year to $1.1 million; the trailing twelve-month figure through Dec 2024 stood at $1.1 million (up 78.98% YoY), and the FY2024 full-year result was $1.1 million, up 78.98% from the prior year.
  • Asset Writedowns and Impairment advanced to $1.1 million in Q1 2024, from $590000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $1.1 million in Q1 2024 to a low of $301000.0 in Q4 2021.
  • A 4-year average of $686250.0 and a median of $694000.0 in 2022 frame the typical range for Asset Writedowns and Impairment.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Integer Holdings 3.34 Bn 3.33 Bn 109.60 Mn

Historic Data

Download Data
DateValue
Mar 29, 2024 1.06 Mn
Mar 29, 2024 1.06 Mn
Dec 31, 2023 590,000.00
Dec 31, 2023 590,000.00
Apr 1, 2022 798,000.00
Apr 1, 2022 798,000.00
Dec 31, 2021 301,000.00
Dec 31, 2021 301,000.00